Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 488 Leukemia 246 Precursor Cell Lymphoblastic Leukemia-Lymphoma 198 Lymphoma 133 Myelodysplastic Syndromes 95 Burkitt Lymphoma 77 Lymphoma, Non-Hodgkin 74 Leukemia, Monocytic, Acute 74 Congenital Abnormalities 73 Leukemia, Myelomonocytic, Acute 71 Leukemia, Erythroblastic, Acute 66 Lymphoma, Large B-Cell, Diffuse 65 Leukemia, Megakaryoblastic, Acute 63 Recurrence 59 Lymphoma, Mantle-Cell 58 Lymphoma, Follicular 42 Hodgkin Disease 40 Leukemia, Myelomonocytic, Chronic 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 34 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 29 Blast Crisis 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, B-Cell, Marginal Zone 21 Leukemia, Myeloid, Chronic-Phase 21 Multiple Myeloma 20 Leukemia, Eosinophilic, Acute 19

Interventions

pembrolizumab 254 Nivolumab 232 Ipilimumab 210 aldesleukin 119 Cyclophosphamide 117 Interleukin-2 88 trametinib 74 dabrafenib 66 Dacarbazine 62 Vemurafenib 60 fludarabine 59 Temozolomide 59 fludarabine phosphate 52 Biopsy 43 Radiosurgery 41 sargramostim 39 Bevacizumab 39 incomplete Freund's adjuvant 35 binimetinib 34 Paclitaxel 32 Magnetic Resonance Spectroscopy 32 atezolizumab 31 Specimen Handling 31 Radiotherapy 31 Cisplatin 31 Introns 30 cobimetinib 29 Blood Specimen Collection 29 encorafenib 28 Carboplatin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡